Wells Fargo’s Urovant Sciences Ltd. UROV Stock Holding History

Wells Fargo’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-302	Closed	-$5K	–	7727
2020 Q4	$5K	Sell	302 -37,396	-99%	-$463K	﹤0.01%	6165
2020 Q3	$352K	Buy	37,698 +37,147	+6,742%	+$330K	﹤0.01%	4609
2020 Q2	$6K	Buy	551 +500	+980%	+$4.8K	﹤0.01%	5956
2020 Q1	$0	Buy	+51	New	+$614	﹤0.01%	7142

Wells Fargo's UROV Position: Q1 2021 in Review

Wells Fargo sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 302 shares — an estimated $5K sold.

Wells Fargo first reported a position in UROV in Q1 2020 and held it in 4 quarters. The position peaked at $352K in Q3 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Wells Fargo reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Wells Fargo sold 302 Urovant Sciences Ltd. shares in Q1 2021, an estimated $5K.
Wells Fargo first reported a position in Urovant Sciences Ltd. in Q1 2020 and held it in 4 quarters.
Wells Fargo's Urovant Sciences Ltd. position peaked at $352K in Q3 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.